Neuropilin structure governs VEGF and semaphorin binding and regulates angiogenesis

被引:190
作者
Geretti, Elena [1 ,2 ]
Shimizu, Akio [1 ,2 ]
Klagsbrun, Michael [1 ,2 ,3 ]
机构
[1] Harvard Univ, Sch Med, Boston, MA 02115 USA
[2] Childrens Hosp, Dept Surg, Vasc Biol Program, Boston, MA 02115 USA
[3] Childrens Hosp, Dept Pathol, Vasc Biol Program, Boston, MA 02115 USA
关键词
neuropilin; VEGF; semaphorin; angiogenesis; axon guidance; cancer; structure;
D O I
10.1007/s10456-008-9097-1
中图分类号
R6 [外科学];
学科分类号
1002 [临床医学]; 100210 [外科学];
摘要
Neuropilins (NRP) play a central role in neuronal and blood vessel development as receptors for two ligand types, the semaphorin (SEMA) family of axon guidance modulators and the VEGF family of angiogenesis stimulators. The role of NRPs in axon guidance is well documented but a role in blood vessel development is less so. NRPs mediate normal developmental angiogenesis as shown in mouse and zebrafish models, and pathological angiogenesis in tumors and retinal disease. The ability of two disparate ligand families to bind to the same receptor is unusual but may be explainable by analysis of neuropilin structure. There are two NRP genes, nrp1 and nrp2. The NRPs have a relatively large extracellular domain consisting of sub domains, which are ligand binding sites. VEGF(165) binds to the b1b2 subdomain, SEMA3A and SEMA3F also bind to b1b2 but to a1a2 as well. Mutagenesis studies have identified NRP amino acids that bind VEGF165 but not SEMA3F. These NRP structural elements might dictate differential SEMA and VEGF165 binding properties, which in turn regulate angiogenesis. This article reviews the latest information of NRP structure and how structure influences angiogenesis. In addition, the role of NRPs in human cancer is addressed.
引用
收藏
页码:31 / 39
页数:9
相关论文
共 98 条
[1]
Structural studies of neuropilin/antibody complexes provide insights into semaphorin and VEGF binding [J].
Appleton, Brent A. ;
Wu, Ping ;
Maloney, Janice ;
Yin, Jian Ping ;
Liang, Wei-Ching ;
Stawicki, Scott ;
Mortara, Kyle ;
Bowman, Krista K. ;
Elliott, J. Michael ;
Desmarais, William ;
Bazan, J. Fernando ;
Bagri, Anil ;
Tessier-Lavigne, Marc ;
Koch, Alexander W. ;
Wu, Yan ;
Watts, Ryan J. ;
Wiesmann, Christian .
EMBO JOURNAL, 2007, 26 (23) :4902-4912
[2]
Baba T, 2007, GYNECOL ONCOL, V105, P703, DOI 10.1016/j.ygyno.2007.02.005
[3]
Bachelder RE, 2001, CANCER RES, V61, P5736
[4]
Bachelder RE, 2002, CANCER RES, V62, P7203
[5]
Bates DO, 2002, CANCER RES, V62, P4123
[6]
Targeting endothelial and tumor cells with semaphorins [J].
Bielenberg, Diane R. ;
Klagsbrun, Michael .
CANCER AND METASTASIS REVIEWS, 2007, 26 (3-4) :421-431
[7]
Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype [J].
Bielenberg, DR ;
Hida, Y ;
Shimizu, A ;
Kaipainen, A ;
Kreuter, M ;
Kim, CC ;
Klagsbrun, M .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (09) :1260-1271
[8]
Vascular endothelial growth factor (VEGF) receptor neuropilin-1's distribution in astrocytic tumors [J].
Broholm, H ;
Laursen, H .
APMIS, 2004, 112 (4-5) :257-263
[9]
Identification of two novel altematively spliced Neuropilin-1 isoforms [J].
Cackowski, FC ;
Xu, L ;
Hu, B ;
Cheng, SY .
GENOMICS, 2004, 84 (01) :82-94
[10]
Cai HB, 1999, J NEUROSCI, V19, P6519